In a previous study [14], we presented follow-up data from 62 patients with primary breast carcinoma in which patients with tumors expressing high DKC1 mRNA levels were characterized by a worse prognosis than patients with intermediate or low levels. Here, DKC1 is linked to breast carcinoma.